INNVENTURE, INC. Research and Development Expense
INNVENTURE, INC. (INV) reported Research and Development Expense of $9.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- INNVENTURE, INC. research and development expense for the quarter ending 2026-06-30 was $9.78M, a 61.17% increase year-over-year.
- INNVENTURE, INC. research and development expense for the quarter ending 2026-03-31 was $7.84M, a 25.38% increase year-over-year.
- INNVENTURE, INC. research and development expense for the quarter ending 2025-12-31 was $6.55M, a 22.72% increase year-over-year.
- INNVENTURE, INC. research and development expense for the quarter ending 2025-09-30 was $6.15M, a 141.69% increase year-over-year.
- INNVENTURE, INC. research and development expense for fiscal 2025 was $25.02M.
- INNVENTURE, INC. research and development expense for fiscal 2023 was $4.00M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.78M 10-Q · filed 2026-08-13 | $17.62M 10-Q · filed 2026-08-13 | $24.17M derived: sum of 3 quarters · filed 2026-08-13 | $30.32M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $7.84M 10-Q · filed 2026-05-14 | $14.39M derived: sum of 2 quarters · filed 2026-05-14 | $20.54M derived: sum of 3 quarters · filed 2026-05-14 | $26.61M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $12.70M derived: sum of 2 quarters · filed 2026-03-30 | $18.77M derived: sum of 3 quarters · filed 2026-08-13 | $25.02M 10-K · filed 2026-03-30 |
| 2025-09-30 | $6.15M 10-Q · filed 2025-11-13 | $12.22M derived: sum of 2 quarters · filed 2026-08-13 | $18.47M 10-Q · filed 2025-11-13 | $23.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $6.07M 10-Q · filed 2026-08-13 | $12.32M 10-Q · filed 2026-08-13 | $17.66M derived: sum of 3 quarters · filed 2026-08-13 | $20.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $6.25M 10-Q · filed 2026-05-14 | $11.59M derived: sum of 2 quarters · filed 2026-05-14 | $14.14M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $5.34M 10-K · filed 2026-03-30 | $7.88M derived: sum of 2 quarters · filed 2026-03-30 | ||
| 2024-10-01 | $2.54M derived: 10-K 9 month − 10-Q 6 month · filed 2026-03-30 | $5.98M 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $2.53M 10-Q · filed 2025-11-13 | $4.30M derived: sum of 2 quarters · filed 2025-11-13 | $5.98M 10-Q · filed 2025-11-13 | $7.14M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.76M 10-Q · filed 2025-08-14 | $3.43M 10-Q · filed 2025-08-14 | $4.61M derived: sum of 3 quarters · filed 2025-08-14 | $5.85M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.67M 10-Q · filed 2025-05-15 | $2.85M derived: sum of 2 quarters · filed 2025-05-15 | $4.09M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $2.42M derived: sum of 2 quarters · filed 2025-04-14 | $4.00M 10-K · filed 2025-04-14 | |
| 2023-09-30 | $1.24M 10-Q · filed 2024-11-14 | $2.82M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Origin Investment Corp I (ORIQ) | $0.090B | 13.93 | |
| CO2 Energy Transition Corp. (NOEM) | United States | $0.040B | |
| Aimei Health Technology Co., Ltd. (AFJK) | United States | $0.038B | |
| Israel Acquisitions Corp (ISRL) | United States | $0.032B | |
| XFLH Capital Corp (XFLH) | United States | $0.139B | |
| Aldel Financial II Inc. (ALDF) | United States | $0.323B |